DK0806957T3 - Kombinationsterapi mod HIV-infektion med anvendelse af HIV-proteaseinhibitoren, indinavir og omvendt transkriptaseinhibitoren, 3TC eventuelt sammen med AZT - Google Patents

Kombinationsterapi mod HIV-infektion med anvendelse af HIV-proteaseinhibitoren, indinavir og omvendt transkriptaseinhibitoren, 3TC eventuelt sammen med AZT

Info

Publication number
DK0806957T3
DK0806957T3 DK96903770T DK96903770T DK0806957T3 DK 0806957 T3 DK0806957 T3 DK 0806957T3 DK 96903770 T DK96903770 T DK 96903770T DK 96903770 T DK96903770 T DK 96903770T DK 0806957 T3 DK0806957 T3 DK 0806957T3
Authority
DK
Denmark
Prior art keywords
indinavir
azt
inhibitor
reverse transcriptase
combination therapy
Prior art date
Application number
DK96903770T
Other languages
Danish (da)
English (en)
Inventor
Emilio A Emini
Jeffrey A Chodakewitz
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0806957T3 publication Critical patent/DK0806957T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96903770T 1995-02-01 1996-01-29 Kombinationsterapi mod HIV-infektion med anvendelse af HIV-proteaseinhibitoren, indinavir og omvendt transkriptaseinhibitoren, 3TC eventuelt sammen med AZT DK0806957T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/382,113 US6689761B1 (en) 1995-02-01 1995-02-01 Combination therapy for HIV infection
PCT/US1996/001417 WO1996023509A1 (en) 1995-02-01 1996-01-29 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc

Publications (1)

Publication Number Publication Date
DK0806957T3 true DK0806957T3 (da) 2003-09-29

Family

ID=23507574

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96903770T DK0806957T3 (da) 1995-02-01 1996-01-29 Kombinationsterapi mod HIV-infektion med anvendelse af HIV-proteaseinhibitoren, indinavir og omvendt transkriptaseinhibitoren, 3TC eventuelt sammen med AZT

Country Status (37)

Country Link
US (1) US6689761B1 (de)
EP (1) EP0806957B1 (de)
JP (1) JPH10513186A (de)
KR (1) KR19980701856A (de)
CN (1) CN1160081C (de)
AR (1) AR002957A1 (de)
AT (1) ATE243519T1 (de)
AU (1) AU711176B2 (de)
BR (1) BR9607714A (de)
CA (1) CA2211973A1 (de)
CO (1) CO4700430A1 (de)
CZ (1) CZ244497A3 (de)
DE (1) DE69628819T2 (de)
DK (1) DK0806957T3 (de)
DZ (1) DZ1988A1 (de)
EA (1) EA000437B1 (de)
EE (1) EE03514B1 (de)
ES (1) ES2200052T3 (de)
FI (1) FI973184L (de)
HR (1) HRP960045B1 (de)
HU (1) HUP9800810A3 (de)
IL (1) IL116925A (de)
IS (1) IS1970B (de)
MX (1) MX9705916A (de)
MY (1) MY121604A (de)
NO (1) NO314568B1 (de)
NZ (1) NZ302153A (de)
PE (1) PE38397A1 (de)
PL (1) PL182742B1 (de)
PT (1) PT806957E (de)
SA (1) SA96160669B1 (de)
SK (1) SK103797A3 (de)
TR (1) TR199700735T1 (de)
TW (1) TW442291B (de)
WO (1) WO1996023509A1 (de)
YU (1) YU49417B (de)
ZA (1) ZA96722B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0942747A1 (de) * 1996-08-26 1999-09-22 Chiron Corporation Impfungstherapie nach einer hiv-infektion
AU6761198A (en) * 1998-03-17 1999-10-11 Julianna Lisziwiewicz Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
CA2374198A1 (en) * 1998-05-29 1999-12-02 Maki Arai Combination therapy for treatment of fiv infection
EP1980617A1 (de) 1998-12-31 2008-10-15 Novartis Vaccines and Diagnostics, Inc. Verbesserte Expression von HIV-Polypeptiden und Herstellung virusähnlicher Partikel
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2452015C (en) 2001-07-05 2012-07-03 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CA2583195A1 (en) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and reverset
WO2007012177A1 (en) * 2005-07-27 2007-02-01 Emil Toma Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy
WO2018128993A1 (en) * 2017-01-04 2018-07-12 Oyagen, Inc. Compounds, compositions, and methods for treating human immunodeficiency virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
RU2139052C1 (ru) 1993-03-31 1999-10-10 Мерк Энд Ко., Инк. Комбинация ингибитора вич-протеазы с другими антивирусными соединениями, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
IL114208A0 (en) 1994-06-27 1995-10-31 Merck & Co Inc Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors

Also Published As

Publication number Publication date
CZ244497A3 (cs) 1998-01-14
PT806957E (pt) 2003-10-31
CN1160081C (zh) 2004-08-04
CA2211973A1 (en) 1996-08-08
CO4700430A1 (es) 1998-12-29
TR199700735T1 (xx) 1998-02-21
IL116925A0 (en) 1996-05-14
HUP9800810A3 (en) 2001-05-28
TW442291B (en) 2001-06-23
YU49417B (sh) 2006-01-16
EA199700150A1 (ru) 1997-12-30
MY121604A (en) 2006-02-28
IS4533A (is) 1997-07-29
PL321660A1 (en) 1997-12-22
AU711176B2 (en) 1999-10-07
IS1970B (is) 2004-12-15
KR19980701856A (ko) 1998-06-25
ZA96722B (en) 1996-08-26
PE38397A1 (es) 1997-10-09
DZ1988A1 (fr) 2002-07-20
EE03514B1 (et) 2001-10-15
FI973184A7 (fi) 1997-09-30
FI973184A0 (fi) 1997-07-31
BR9607714A (pt) 1998-01-13
NO973533D0 (no) 1997-07-31
PL182742B1 (pl) 2002-02-28
NZ302153A (en) 1998-12-23
CN1179722A (zh) 1998-04-22
DE69628819T2 (de) 2004-05-13
AU4774896A (en) 1996-08-21
ES2200052T3 (es) 2004-03-01
HK1004659A1 (en) 1998-12-04
EP0806957A1 (de) 1997-11-19
EP0806957B1 (de) 2003-06-25
EE9700165A (et) 1998-02-16
HRP960045A2 (en) 1997-10-31
US6689761B1 (en) 2004-02-10
WO1996023509A1 (en) 1996-08-08
MX9705916A (es) 1997-10-31
SA96160669B1 (ar) 2006-07-30
ATE243519T1 (de) 2003-07-15
EA000437B1 (ru) 1999-08-26
HUP9800810A2 (hu) 1998-07-28
FI973184L (fi) 1997-09-30
IL116925A (en) 2000-07-26
NO314568B1 (no) 2003-04-14
JPH10513186A (ja) 1998-12-15
HRP960045B1 (en) 2004-06-30
NO973533L (no) 1997-10-01
SK103797A3 (en) 1998-02-04
YU6396A (sh) 1999-06-15
DE69628819D1 (de) 2003-07-31
AR002957A1 (es) 1998-05-27

Similar Documents

Publication Publication Date Title
FI953954A0 (fi) HIV:n käänteistranskriptaasin inhibiittoreita
FI893962A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat hyödyllisiä AIDS:in hoidossa
TR199800117A3 (tr) Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi.
FI911528A0 (fi) Mot non-a, non-b-hepatisvirus riktade, med antikroppar immunokemiskt reaktiva peptider.
FI973184L (fi) Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibiittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdollisesti yhdessä AZT:n, DDI:n tai DDC:n kanssa
FI912926A7 (fi) HIV-käänteistranskriptaasin inhibiittoreita
DK0522059T3 (da) Fastholdelsesindretning og forbindelsesindretning, som indbefatter fastholdelsesindretningen
FI884669A0 (fi) Maraging-staol.
NO900033L (no) Laasebolt og roerklammer.
IT8921832A0 (it) Rubinetto inviolabile.
NO910590D0 (no) Hydratiserte silikater, fremgangsmaate for deres fremstilling og anvendelse.
NO901758L (no) Reninhemmende dipeptider, fremgangsmaate for deres fremstilling, midler som inneholder disse og deres anvendelse.
ES1033258Y (es) Collarin bisagra perfeccionado.
FR2708445B1 (fr) Cuillère à diffuseur à usage unique.
ES1027737Y (es) Canutillo perfeccionado.
FR2710832B1 (fr) Articulateur dentaire.
ES1028704Y (es) Conmutador dos entradas una salida.
GB9520721D0 (en) HIV reverse transcriptase inhibitors
KR950031759U (ko) 피. 시. 비 기판 고정장치
FI962173A0 (fi) Med bladskydd foersedd saogstaellning
ES1027916Y (es) Colgante perfeccionado.
ES1028505Y (es) Pulsera perfeccionada.
ES1028580Y (es) Pulsera perfeccionada.
ES1028504Y (es) Pulsera perfeccionada.
ES1027074Y (es) Pulsador perfeccionado.